Evidence map›Paper›PMID 27735937›Full record

ArticleCell death & disease2016

XAB2 functions in mitotic cell cycle progression via transcriptional regulation of CENPE.

Shuai Hou, Na Li, Qian Zhang, Hui Li, Xinyue Wei, Tian Hao, Yue Li, Sikandar Azam, Caigang Liu, Wei Cheng and 4 more

Open access · goldAbstract read
In one paragraph

Article in Cell death & disease, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 39 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Genome-wide comparison andFrontiers in genetics · 2022
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 1 country.

Shuai HouInstitute of Cancer Stem Cell, Cancer Center, Dalian Medical University, Dalian, China.
Na LiDepartment of Oncology, Second Affiliated Hospital, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China.
Qian ZhangInstitute of Cancer Stem Cell, Cancer Center, Dalian Medical University, Dalian, China.
Hui LiInstitute of Cancer Stem Cell, Cancer Center, Dalian Medical University, Dalian, China.
Xinyue WeiInstitute of Cancer Stem Cell, Cancer Center, Dalian Medical University, Dalian, China.
Tian HaoInstitute of Cancer Stem Cell, Cancer Center, Dalian Medical University, Dalian, China.
Yue LiBreast Disease and Reconstruction Center, Breast Cancer Key Lab of Dalian, Second Affiliated Hospital, Dalian Medical University, Dalian, China.
Sikandar AzamInstitute of Cancer Stem Cell, Cancer Center, Dalian Medical University, Dalian, China.
Caigang LiuBreast Disease and Reconstruction Center, Breast Cancer Key Lab of Dalian, Second Affiliated Hospital, Dalian Medical University, Dalian, China.
Wei ChengInstitute of Cancer Stem Cell, Cancer Center, Dalian Medical University, Dalian, China.
Bilian JinInstitute of Cancer Stem Cell, Cancer Center, Dalian Medical University, Dalian, China.
Quentin LiuInstitute of Cancer Stem Cell, Cancer Center, Dalian Medical University, Dalian, China.
Man LiDepartment of Oncology, Second Affiliated Hospital, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China.
Haixin LeiInstitute of Cancer Stem Cell, Cancer Center, Dalian Medical University, Dalian, China.
Dalian Medical University · CNSecond Affiliated Hospital of Dalian Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Xeroderma pigmentosum group A (XPA)-binding protein 2 (XAB2) is a multi-functional protein that plays critical role in processes including transcription, transcription-coupled DNA repair, pre-mRNA splicing, homologous recombination and mRNA export. Microarray analysis on gene expression in XAB2 knockdown cells reveals that many genes with significant change in expression function in mitotic cell cycle regulation. Fluorescence-activated cell scanner analysis confirmed XAB2 depletion led to cell arrest in G2/M phase, mostly at prophase or prometaphase. Live cell imaging further disclosed that XAB2 knockdown induced severe mitotic defects including chromosome misalignment and defects in segregation, leading to mitotic arrest, mitotic catastrophe and subsequent cell death. Among top genes down-regulated by XAB2 depletion is mitotic motor protein centrosome-associated protein E (CENPE). Knockdown CENPE showed similar phenotypes to loss of XAB2, but CENPE knockdown followed by XAB2 depletion did not further enhance cell cycle arrest. Luciferase assay on CENPE promoter showed that overexpression of XAB2 increased luciferase activity, whereas XAB2 depletion resulted in striking reduction of luciferase activity. Further mapping revealed a region in CENPE promoter that is required for the transcriptional regulation by XAB2. Moreover, ChIP assay showed that XAB2 interacted with CENPE promoter. Together, these results support a novel function of XAB2 in mitotic cell cycle regulation, which is partially mediated by transcription regulation on CENPE.

Indexed as

Gene Expression RegulationTranscription, GeneticCell Cycle CheckpointsCell DeathCell NucleusChromosomal Proteins, Non-HistoneChromosome SegregationDNA BreaksGene DeletionGene Knockdown TechniquesHEK293 CellsHeLa CellsHumansMicrotubulesMitosisOligonucleotide Array Sequence Analysiscentromere protein EChromosomal Proteins, Non-HistoneRNA Splicing FactorsTranscription FactorsXAB2 protein, human

Identifiers

PMID27735937
PMCPMC5133980
OpenAlexW2530990615

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.